Ástralía - enska - Department of Health (Therapeutic Goods Administration)

rapp australia pty ltd - 13366 - resuscitator, pulmonary, gas-powered - for pre-hospital/first aid ventilation of a person in respiratory arrest and/or for the provision of 100% oxygen on demand to a spontaneously breathing person.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

rapp australia pty ltd - 17591 - resuscitator, pulmonary, manual, reusable - to manually ventilate a person

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

rapp australia pty ltd - 36607 - suction unit, gas powered - provision of suction by venturi action from a source of pressure regulated compressed gas, for applications such as routine airway aspiration or airway maintenance when connected to tubing and suction devices, in medical facilities or ambulances.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

rapp australia pty ltd - 17169 - valve, demand - regulates therapeutic gas flow "on demand" in response to a negative pressure. can provide therapeutic gas to a breathing victim, with minimal respiratory effort or to deliver therapeutic gas for pain relief and analgesia. can be used to demand fill a bag valve mask.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - ibuprofen, quantity: 400 mg - tablet, film coated - excipient ingredients: sodium lauryl sulfate; povidone; colloidal anhydrous silica; macrogol 6000; stearic acid; croscarmellose sodium; titanium dioxide; purified water; purified talc; hypromellose; microcrystalline cellulose; lactose monohydrate - for the temporary relief of pain and/or inflammation associated with headache, migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, arthritis, rheumatic pain and aches and pains associated with colds and flu. reduces fever.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - etoricoxib -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 30 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; calcium hydrogen phosphate; carnauba wax; croscarmellose sodium; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow; indigo carmine aluminium lake - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 120 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; carnauba wax; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; iron oxide yellow - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

organon pharma pty ltd - etoricoxib, quantity: 60 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; carnauba wax; calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; iron oxide yellow - arcoxia is indicated for: - symptomatic treatment of the signs and symptoms of osteoarthritis (oa). - treatment of acute gouty arthritis. - treatment of acute pain, including that related to primary dysmenorrhea and minor dental procedures. the decision to prescribe a selective cox-2 inhibitor should be based on an assessment of the individual patient's overall risks.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

allied scientific products pty ltd - 35277 - prosthesis, internal, testicle - round high-cohesive silicone gel-filled mammary implant with barrier shell, round low profile. these testicular implants are designed to restore the natural scrotal contour following trauma, inhibited development, disease or surgical intervention.